Observational study of Long-term follow-up of post-myocardial infarction

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patient with recent (≤3 months) acute myocardial infarction (first or recurrent heart attack); Patient seen during the first or second consultation after acute myocardial infarction; Infarct defined by the presence at least of two among the following criteria: symptomatic (characteristic pain), electric (Q wave and / or ST elevation in at least two adjacent leads), enzymatic (elevated CPKMB and / or troponin greater than 2 twice the normal value); Patient who may be followed for 6 years; Patient without a non-cardiovascular disease that is life-threatening in the short term (≤3 months); Patient not included in a clinical trial of an non marketed drug; Patient not affected by a language barrier (unable to read the information sheet or complete the self-administered questionnaires); Patient agreeing to participate.","clusion_E":""}